Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
VR Resources Confirms Gold in Porphyry Intrusion Cutting Nickel Sulfide Mineralization at Silverback Project in Ontario
-
Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference
-
Abcourt Intersects 10.4 g/t Gold over 12 Metres in Channel on the New Stripping carried out in the Cartwright Area of the Flordin Project
-
Soligenix, Inc. to Present at the 2024 ThinkEquity Conference
-
PeopleOne Health Secures up to $32.3 Million Series B Funding Led by GV (Google Ventures) to Expand Access to Affordable, High-Quality Primary Care
-
Midland, in Partnership with RTEC, Intersects Several New Spodumene Pegmatites During the 2024 Drilling Program on the Galinée Project
-
TeraWulf Inc. Announces Upsize and Pricing of $425 Million Convertible Notes Offering
-
Prelude Therapeutics Presents New Data from SMARCA Degrader Portfolio at the 36th EORTC-NCI-AACR Symposium
-
Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
-
ZenaTech’s AI Drone Company Acquires Drone Design Patent From Former Parent Company
-
American Poll on Immigration and Identities Launched with US Election Less than Two Weeks Away
-
Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference
-
BridgeBio Shares Positive Data from High Dose Cohort of Phase 1/2 CANaspire Study of Gene Therapy BBP-812 for Canavan Disease at ESGCT 2024
-
AGF Investments Announces October 2024 Cash Distributions for AGF Enhanced U.S. Equity Income Fund, AGF Total Return Bond Fund and AGF Systematic Global Infrastructure ETF
-
Invesco Ltd: Form 8.3 - PRS REIT PLC/The; Opening Position Disclosure
-
Altisource Announces Third Quarter 2024 Financial Results
-
Form 8.3 - Learning Technologies Group Plc
-
OKX Lists Scroll (SCR) and Goatseus Maximus (GOAT) on its Perpetual Futures Market
-
Form 8.3 - Balanced Commercial Property Trust Limited
-
New Report Details Reductions in Addiction Stigma in Ohio
-
The Joint Corp. to Host Conference Call on Thursday, November 7th to Discuss Third Quarter 2024 Results
-
Sable Starts 2024 – 2025 Field Season at the Don Julio Project, San Juan, Argentina
-
Rogers Communications Declares 50 Cents per Share Quarterly Dividend
-
Rogers Communications Reports Third Quarter 2024 Results
-
Nasdaq Announces Quarterly Dividend of $0.24 Per Share
-
Valley National Bancorp Announces Third Quarter 2024 Results
-
Virtu Announces Third Quarter 2024 Results
-
Migrant Rights Network: We Have a Consensus: Permanent Residency & Rights, Not Cuts
-
The Great Twine Round-Up Comes to Alberta with $12,000 in total Cash Prizes
-
Pool Corporation Reports Third Quarter Results
-
DTE Energy reports third quarter 2024 accomplishments, earnings and investments in improving energy infrastructure
-
EyePoint Pharmaceuticals Announces First Patient Dosed in Global Phase 3 LUGANO Clinical Trial of DURAVYUTM for the Treatment of Wet Age-Related Macular Degeneration
-
The Simply Good Foods Company Reports Fiscal Fourth Quarter and Full Fiscal Year 2024 Financial Results and Provides Full Fiscal Year 2025 Outlook
-
Ultralife Corporation to Report Third Quarter Results on November 8, 2024
-
Epitopea Closes USD $31 million Pre-Series A Financing
-
BranchOut Food Shareholder Update: Projects $15M Run Rate and Positive Cash Flow for Q1 2025 Amid Surge in New Orders as Peru Factory Opens
-
New York’s RTS awards NFI subsidiary New Flyer order for 44 Xcelsior heavy-duty transit buses
-
Volvo Study Reveals that rising fuel prices and environmental concerns are driving Gen Z to consider plug-in hybrids for their future vehicle choice
-
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
-
Beasley Broadcast Group, Inc. Appoints Lauren Burrows Coleman as Chief Financial Officer
-
KCA Confirms Commitment to Xali Gold’s El Oro Tailings Project
-
Kymera Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader, for the Treatment of TH2 Immuno-Inflammatory Diseases
-
Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference
-
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
-
Auron Presents New Preclinical Data for Lead Program AUTX-703 Across Multiple Cancer Types
-
Nasdaq Reports Third Quarter 2024 Results; Fourth Consecutive Quarter of Double-Digit Solutions Revenue Growth
-
Rivian and Patagonia Partner with Sol Systems to Drive Renewable Energy in Stokes County, NC
-
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
-
iTeos Therapeutics to Highlight Inupadenant Preclinical, Translational, and Phase 2 A2A-005 Clinical Trial Data in 2L NSCLC at ESMO Immuno-Oncology Congress
-
Flock Safety Launches First-of-Its-Kind Sideshow Detection Technology to Help Communities Combat Illegal Sideshows
